Ronald Silver - 23 Nov 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Principal Accounting Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
23 Nov 2021
Net transactions value
-$16,930
Form type
4
Filing time
24 Nov 2021, 15:07:30 UTC
Previous filing
18 Aug 2021
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale $8,673 -749 -1.2% $11.58 61,926 23 Nov 2021 Direct F1
transaction IRWD Class A Common Stock Sale $8,257 -713 -1.2% $11.58 61,213 23 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 100% of the reporting person's restricted stock units granted on December 16, 2019.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on December 4, 2020.